Concepedia
Statistics
Publications
6
Citations
754
H-Index
Active since
2001
Affiliations
Nagoya University(Current)
Nippon Shinyaku (Japan)
Japan Science and Technology Agency
Kyoto University Hospital
Tatsushi Wakayama is an author at Nagoya University specializing in genetics, bcr-abl inhibitors, and pharmacology.
Publications per year
2001–2007
Recruitment of Mec1 and Ddc1 Checkpoint Proteins to Double-Strand Breaks Through Distinct Mechanisms
Tae Kondo, Tatsushi Wakayama, Takahiro Naiki et al. · Science · 2001 · 254 citations
Life Sciences, Genetics, Molecular Biology +17
NS-187, a potent and selective dual Bcr-Abl/Lyn tyrosine kinase inhibitor, is a novel agent for imatinib-resistant leukemia
Shinya Kimura, Haruna Naito, Hidekazu Segawa et al. · Blood · 2005 · 244 citations · Full text
Medicine, Oncology, Pharmacology +7
Pie1, a Protein Interacting with Mec1, Controls Cell Growth and Checkpoint Responses in <i>Saccharomyces cerevisiae</i>
Tatsushi Wakayama, Tae Kondo, Seiko Ando et al. · Molecular and Cellular Biology · 2001 · 117 citations · Full text
Life Sciences, Genetics, Molecular Biology +14
Association of Rad9 with Double-Strand Breaks through a Mec1-Dependent Mechanism
Takahiro Naiki, Tatsushi Wakayama, Daisuke Nakada et al. · Molecular and Cellular Biology · 2004 · 56 citations · Full text
In vivo antiproliferative effect of NS-187, a dual Bcr-Abl/Lyn tyrosine kinase inhibitor, on leukemic cells harbouring Abl kinase domain mutations
Haruna Naito, Shinya Kimura, Shinya Kimura et al. · Leukemia Research · 2006 · 50 citations
Medicine, Oncology, Pharmacology +15
1–5 of 6